2018
DOI: 10.1183/13993003.00817-2018
|View full text |Cite
|
Sign up to set email alerts
|

Aminopeptidase antibodies in mesothelioma: new wine deserves new sacks

Abstract: Aminopeptidase antibodies are a new class of agents in mesothelioma; their development will require strategic clinical trials. Exploring activity and efficacy according to old paradigms may lead to their disruptive characteristics being disregarded.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 26 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?